Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study

Diabetes Research and Clinical Practice

Volumn 77, Issue 3, 2007, Pages 459-464

  Hadaegh, F ^a   Harati, H ^a   Ghasemi, A ^a   Tohidi, M ^a   Zabetian, A ^a   Mehrabi, Y ^a   Azizi, F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Agreement; Impaired fasting glucose; Impaired glucose tolerance; Risk assessment

Indexed keywords

GLUCOSE;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; COLORIMETRY; DIABETES MELLITUS; DIAGNOSTIC KIT; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IRAN; LABORATORY TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; URBAN POPULATION; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; IRAN; LIKELIHOOD FUNCTIONS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE;

EID: 34547684729     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.02.008     Document Type: Article

References (26)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
2. Gomez-Perez F.J., Aguilar-Salinas C.A., Lopez-Alvarenga J.C., Perez-Jauregui J., Guillen-Pineda L.E., and Rull J.A. Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 21 (1998) 1886-1888
3. Harris M.I., Eastman R.C., Cowie C.C., Flegal K.M., and Eberhardt M.S. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 20 (1997) 1859-1862
4. de Vegt F., Dekker J.M., Stehouwer C.D., Nijpels G., Bouter L.M., and Heine R.J. The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care 21 (1998) 1686-1690
5. Shaw J.E., Zimmet P.Z., de Courten M., Dowse G.K., Chitson P., Gareeboo H., et al. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?. Diabetes Care 22 (1999) 399-402
6. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
7. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
8. Drzewoski J., and Czupryniak L. Concordance between fasting and 2-h post-glucose challenge criteria for the diagnosis of diabetes mellitus and glucose intolerance in high risk individuals. Diabetes Med. 18 (2001) 29-31
9. Tai E.S., Goh S.Y., Lee J.J., Wong M.S., Heng D., Hughes K., et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27 (2004) 1728-1734
10. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20 (1997) 537-544
11. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344 (2001) 1343-1350
12. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346 (2002) 393-403
13. STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359 (2002) 2072-2077
14. Azizi F., Rahmani M., Emami H., Mirmiran P., Hajipour R., Madjid M., et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed. 47 (2002) 408-426
15. Jekel J.F., Katz D.L., and Elmore J.G. Epidemiology, Biostatistics and Preventive Medicine (2001), W.B. Saunders Company, USA pp. 105-118
16. Jaeschke R., Guyatt G., and Lijmer J. Diagnostic tests. In: Guyatt G., and Rennie D. (Eds). Users' Guides to the Medical Literature (2002), JAMA Press, USA 121-140
17. Altman D.G. Practical Statistics for Medical Research (1991), Champan and Hall, London 404 pp
18. Gabir M.M., Hanson R.L., Dabelea D., Imperatore G., Roumain J., Bennett P.H., et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23 (2000) 1108-1112
19. de Vegt F., Dekker J.M., Jager A., Hienkens E., Kostense P.J., Stehouwer C.D., et al. Relation of impaired fasting and post load glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 285 (2001) 2109-2113
20. Borch-Johnsen K., Colagiuri S., Balkau B., Glumer C., Carstensen B., Ramachandran A., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47 (2004) 1396-1402
21. Unwin N., Shaw J., Zimmet P., and Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med. 19 (2002) 708-723
22. Nelson K.M., and Boyko E.J. Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey. Diabetes Care 26 (2003) 2058-2062
23. Franciosi M., De Berardis G., Rossi M.C., Sacco M., Belfiglio M., Pellegrini F., et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 28 (2005) 1187-1194
24. The DECODE-DECODA Study Group. Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia 46 (2003) 1063-1070
25. Ruige J.B., de Neeling J.N., Kostense P.J., Bouter L.M., and Heine R.J. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 20 (1997) 491-496
26. Baan C.A., Ruige J.B., Stolk R.P., Witteman J.C., Dekker J.M., Heine R.J., et al. Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 22 (1999) 213-219